Report Detail
Global and United States HIV Diagnostics Market Size, Status and Forecast 2020-2026
- RnM3476243 |
- 03 December, 2020 |
- Global |
- 128 Pages |
- QYResearch |
- Other
Global HIV Diagnostics Scope and Market Size
HIV Diagnostics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global HIV Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Market segment by Type, the product can be split into
Consumables
Assay, Kits and Reagents
Other Consumables
Instruments
Software and Services
Market segment by Application, split into
Antibody Tests
Viral Load Tests
CD4 Tests
Tests for Early Infant Diagnosis
Tests for Viral Identification
Based on regional and country-level analysis, the HIV Diagnostics market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
In the competitive analysis section of the report, leading as well as prominent players of the global HIV Diagnostics market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The key players covered in this study
Abbott
Abbott Healthcare
Abbvie Inc.
Brsitol-Myers Squibb
Janssen Therapeutics
Gilead Sciences
Merck & Co. Inc
VIIV Healthcare
BD Biosciences
Beckman Coulter
Partec
Sysmex
Apogee Flow Systems
PointCare Technologies Inc.
Zyomyx Inc.
Mylan inc.
Roche Diagnostics
Siemens Healthcare
Qiagen
BioMerieux
1 Report Overview
- 1.1 Study Scope
- 1.2 Market Analysis by Type
- 1.2.1 Global HIV Diagnostics Market Size Growth Rate by Type: 2020 VS 2026
- 1.2.2 Consumables
- 1.2.3 Assay, Kits and Reagents
- 1.2.4 Other Consumables
- 1.2.5 Instruments
- 1.2.6 Software and Services
- 1.3 Market by Application
- 1.3.1 Global HIV Diagnostics Market Share by Application: 2020 VS 2026
- 1.3.2 Antibody Tests
- 1.3.3 Viral Load Tests
- 1.3.4 CD4 Tests
- 1.3.5 Tests for Early Infant Diagnosis
- 1.3.6 Tests for Viral Identification
- 1.4 Study Objectives
- 1.5 Years Considered
2 Global Growth Trends
- 2.1 Global HIV Diagnostics Market Perspective (2015-2026)
- 2.2 Global HIV Diagnostics Growth Trends by Regions
- 2.2.1 HIV Diagnostics Market Size by Regions: 2015 VS 2020 VS 2026
- 2.2.2 HIV Diagnostics Historic Market Share by Regions (2015-2020)
- 2.2.3 HIV Diagnostics Forecasted Market Size by Regions (2021-2026)
- 2.3 Industry Trends and Growth Strategy
- 2.3.1 Market Trends
- 2.3.2 Market Drivers
- 2.3.3 Market Challenges
- 2.3.4 Market Restraints
3 Competition Landscape by Key Players
- 3.1 Global Top HIV Diagnostics Players by Market Size
- 3.1.1 Global Top HIV Diagnostics Players by Revenue (2015-2020)
- 3.1.2 Global HIV Diagnostics Revenue Market Share by Players (2015-2020)
- 3.2 Global HIV Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 Players Covered: Ranking by HIV Diagnostics Revenue
- 3.4 Global HIV Diagnostics Market Concentration Ratio
- 3.4.1 Global HIV Diagnostics Market Concentration Ratio (CR5 and HHI)
- 3.4.2 Global Top 10 and Top 5 Companies by HIV Diagnostics Revenue in 2019
- 3.5 Key Players HIV Diagnostics Area Served
- 3.6 Key Players HIV Diagnostics Product Solution and Service
- 3.7 Date of Enter into HIV Diagnostics Market
- 3.8 Mergers & Acquisitions, Expansion Plans
4 HIV Diagnostics Breakdown Data by Type (2015-2026)
- 4.1 Global HIV Diagnostics Historic Market Size by Type (2015-2020)
- 4.2 Global HIV Diagnostics Forecasted Market Size by Type (2021-2026)
5 HIV Diagnostics Breakdown Data by Application (2015-2026)
- 5.1 Global HIV Diagnostics Historic Market Size by Application (2015-2020)
- 5.2 Global HIV Diagnostics Forecasted Market Size by Application (2021-2026)
6 North America
- 6.1 North America HIV Diagnostics Market Size (2015-2026)
- 6.2 North America HIV Diagnostics Market Size by Type (2015-2020)
- 6.3 North America HIV Diagnostics Market Size by Application (2015-2020)
- 6.4 North America HIV Diagnostics Market Size by Country (2015-2020)
- 6.4.1 United States
- 6.4.2 Canada
7 Europe
- 7.1 Europe HIV Diagnostics Market Size (2015-2026)
- 7.2 Europe HIV Diagnostics Market Size by Type (2015-2020)
- 7.3 Europe HIV Diagnostics Market Size by Application (2015-2020)
- 7.4 Europe HIV Diagnostics Market Size by Country (2015-2020)
- 7.4.1 Germany
- 7.4.2 France
- 7.4.3 U.K.
- 7.4.4 Italy
- 7.4.5 Russia
- 7.4.6 Nordic
- 7.4.7 Rest of Europe
8 China
- 8.1 China HIV Diagnostics Market Size (2015-2026)
- 8.2 China HIV Diagnostics Market Size by Type (2015-2020)
- 8.3 China HIV Diagnostics Market Size by Application (2015-2020)
- 8.4 China HIV Diagnostics Market Size by Region (2015-2020)
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 South Korea
- 8.4.4 Southeast Asia
- 8.4.5 India
- 8.4.6 Australia
- 8.4.7 Rest of Asia-Pacific
9 Japan
- 9.1 Japan HIV Diagnostics Market Size (2015-2026)
- 9.2 Japan HIV Diagnostics Market Size by Type (2015-2020)
- 9.3 Japan HIV Diagnostics Market Size by Application (2015-2020)
- 9.4 Japan HIV Diagnostics Market Size by Country (2015-2020)
- 9.4.1 Mexico
- 9.4.2 Brazil
10 Southeast Asia
- 10.1 Southeast Asia HIV Diagnostics Market Size (2015-2026)
- 10.2 Southeast Asia HIV Diagnostics Market Size by Type (2015-2020)
- 10.3 Southeast Asia HIV Diagnostics Market Size by Application (2015-2020)
- 10.4 Southeast Asia HIV Diagnostics Market Size by Country (2015-2020)
- 10.4.1 Turkey
- 10.4.2 Saudi Arabia
- 10.4.3 UAE
- 10.4.4 Rest of Middle East & Africa
11 Key Players Profiles
- 11.1 Abbott
- 11.1.1 Abbott Company Details
- 11.1.2 Abbott Business Overview
- 11.1.3 Abbott HIV Diagnostics Introduction
- 11.1.4 Abbott Revenue in HIV Diagnostics Business (2015-2020))
- 11.1.5 Abbott Recent Development
- 11.2 Abbott Healthcare
- 11.2.1 Abbott Healthcare Company Details
- 11.2.2 Abbott Healthcare Business Overview
- 11.2.3 Abbott Healthcare HIV Diagnostics Introduction
- 11.2.4 Abbott Healthcare Revenue in HIV Diagnostics Business (2015-2020)
- 11.2.5 Abbott Healthcare Recent Development
- 11.3 Abbvie Inc.
- 11.3.1 Abbvie Inc. Company Details
- 11.3.2 Abbvie Inc. Business Overview
- 11.3.3 Abbvie Inc. HIV Diagnostics Introduction
- 11.3.4 Abbvie Inc. Revenue in HIV Diagnostics Business (2015-2020)
- 11.3.5 Abbvie Inc. Recent Development
- 11.4 Brsitol-Myers Squibb
- 11.4.1 Brsitol-Myers Squibb Company Details
- 11.4.2 Brsitol-Myers Squibb Business Overview
- 11.4.3 Brsitol-Myers Squibb HIV Diagnostics Introduction
- 11.4.4 Brsitol-Myers Squibb Revenue in HIV Diagnostics Business (2015-2020)
- 11.4.5 Brsitol-Myers Squibb Recent Development
- 11.5 Janssen Therapeutics
- 11.5.1 Janssen Therapeutics Company Details
- 11.5.2 Janssen Therapeutics Business Overview
- 11.5.3 Janssen Therapeutics HIV Diagnostics Introduction
- 11.5.4 Janssen Therapeutics Revenue in HIV Diagnostics Business (2015-2020)
- 11.5.5 Janssen Therapeutics Recent Development
- 11.6 Gilead Sciences
- 11.6.1 Gilead Sciences Company Details
- 11.6.2 Gilead Sciences Business Overview
- 11.6.3 Gilead Sciences HIV Diagnostics Introduction
- 11.6.4 Gilead Sciences Revenue in HIV Diagnostics Business (2015-2020)
- 11.6.5 Gilead Sciences Recent Development
- 11.7 Merck & Co. Inc
- 11.7.1 Merck & Co. Inc Company Details
- 11.7.2 Merck & Co. Inc Business Overview
- 11.7.3 Merck & Co. Inc HIV Diagnostics Introduction
- 11.7.4 Merck & Co. Inc Revenue in HIV Diagnostics Business (2015-2020)
- 11.7.5 Merck & Co. Inc Recent Development
- 11.8 VIIV Healthcare
- 11.8.1 VIIV Healthcare Company Details
- 11.8.2 VIIV Healthcare Business Overview
- 11.8.3 VIIV Healthcare HIV Diagnostics Introduction
- 11.8.4 VIIV Healthcare Revenue in HIV Diagnostics Business (2015-2020)
- 11.8.5 VIIV Healthcare Recent Development
- 11.9 BD Biosciences
- 11.9.1 BD Biosciences Company Details
- 11.9.2 BD Biosciences Business Overview
- 11.9.3 BD Biosciences HIV Diagnostics Introduction
- 11.9.4 BD Biosciences Revenue in HIV Diagnostics Business (2015-2020)
- 11.9.5 BD Biosciences Recent Development
- 11.10 Beckman Coulter
- 11.10.1 Beckman Coulter Company Details
- 11.10.2 Beckman Coulter Business Overview
- 11.10.3 Beckman Coulter HIV Diagnostics Introduction
- 11.10.4 Beckman Coulter Revenue in HIV Diagnostics Business (2015-2020)
- 11.10.5 Beckman Coulter Recent Development
- 11.11 Partec
- 10.11.1 Partec Company Details
- 10.11.2 Partec Business Overview
- 10.11.3 Partec HIV Diagnostics Introduction
- 10.11.4 Partec Revenue in HIV Diagnostics Business (2015-2020)
- 10.11.5 Partec Recent Development
- 11.12 Sysmex
- 10.12.1 Sysmex Company Details
- 10.12.2 Sysmex Business Overview
- 10.12.3 Sysmex HIV Diagnostics Introduction
- 10.12.4 Sysmex Revenue in HIV Diagnostics Business (2015-2020)
- 10.12.5 Sysmex Recent Development
- 11.13 Apogee Flow Systems
- 10.13.1 Apogee Flow Systems Company Details
- 10.13.2 Apogee Flow Systems Business Overview
- 10.13.3 Apogee Flow Systems HIV Diagnostics Introduction
- 10.13.4 Apogee Flow Systems Revenue in HIV Diagnostics Business (2015-2020)
- 10.13.5 Apogee Flow Systems Recent Development
- 11.14 PointCare Technologies Inc.
- 10.14.1 PointCare Technologies Inc. Company Details
- 10.14.2 PointCare Technologies Inc. Business Overview
- 10.14.3 PointCare Technologies Inc. HIV Diagnostics Introduction
- 10.14.4 PointCare Technologies Inc. Revenue in HIV Diagnostics Business (2015-2020)
- 10.14.5 PointCare Technologies Inc. Recent Development
- 11.15 Zyomyx Inc.
- 10.15.1 Zyomyx Inc. Company Details
- 10.15.2 Zyomyx Inc. Business Overview
- 10.15.3 Zyomyx Inc. HIV Diagnostics Introduction
- 10.15.4 Zyomyx Inc. Revenue in HIV Diagnostics Business (2015-2020)
- 10.15.5 Zyomyx Inc. Recent Development
- 11.16 Mylan inc.
- 10.16.1 Mylan inc. Company Details
- 10.16.2 Mylan inc. Business Overview
- 10.16.3 Mylan inc. HIV Diagnostics Introduction
- 10.16.4 Mylan inc. Revenue in HIV Diagnostics Business (2015-2020)
- 10.16.5 Mylan inc. Recent Development
- 11.17 Roche Diagnostics
- 10.17.1 Roche Diagnostics Company Details
- 10.17.2 Roche Diagnostics Business Overview
- 10.17.3 Roche Diagnostics HIV Diagnostics Introduction
- 10.17.4 Roche Diagnostics Revenue in HIV Diagnostics Business (2015-2020)
- 10.17.5 Roche Diagnostics Recent Development
- 11.18 Siemens Healthcare
- 10.18.1 Siemens Healthcare Company Details
- 10.18.2 Siemens Healthcare Business Overview
- 10.18.3 Siemens Healthcare HIV Diagnostics Introduction
- 10.18.4 Siemens Healthcare Revenue in HIV Diagnostics Business (2015-2020)
- 10.18.5 Siemens Healthcare Recent Development
- 11.19 Qiagen
- 10.19.1 Qiagen Company Details
- 10.19.2 Qiagen Business Overview
- 10.19.3 Qiagen HIV Diagnostics Introduction
- 10.19.4 Qiagen Revenue in HIV Diagnostics Business (2015-2020)
- 10.19.5 Qiagen Recent Development
- 11.20 BioMerieux
- 10.20.1 BioMerieux Company Details
- 10.20.2 BioMerieux Business Overview
- 10.20.3 BioMerieux HIV Diagnostics Introduction
- 10.20.4 BioMerieux Revenue in HIV Diagnostics Business (2015-2020)
- 10.20.5 BioMerieux Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
- 13.1 Research Methodology
- 13.1.1 Methodology/Research Approach
- 13.1.2 Data Source
- 13.2 Disclaimer
Summary:
Get latest Market Research Reports on HIV Diagnostics. Industry analysis & Market Report on HIV Diagnostics is a syndicated market report, published as Global and United States HIV Diagnostics Market Size, Status and Forecast 2020-2026. It is complete Research Study and Industry Analysis of HIV Diagnostics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
